Engineering a nanoantibiotic system displaying dual mechanism of action
Open Access
- 9 April 2024
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (16)
Abstract
In recent decades, peptide amphiphiles (PAs) have established themselves as promising self-assembling bioinspired materials in a wide range of medical fields. Herein, we report a dual-therapeutic system constituted by an antimicrobial PA and a cylindrical protease inhibitor (LJC) to achieve broad antimicrobial spectrum and to enhance therapeutic efficacy. We studied two strategies: PA–LJC nanostructures ( Encapsulation ) and PA nanostructures + free LJC ( Combination ). Computational modeling using a molecular theory for amphiphile self-assembly captures and explains the morphology of PA–LJC nanostructures and the location of encapsulated LJC in agreement with transmission electron microscopy and two-dimensional (2D) NMR observations. The morphology and release profile of PA–LJC assemblies are strongly correlated to the PA:LJC ratio: high LJC loading induces an initial burst release. We then evaluated the antimicrobial activity of our nanosystems toward gram-positive and gram-negative bacteria. We found that the Combination broadens the spectrum of LJC, reduces the therapeutic concentrations of both agents, and is not impacted by the inoculum effect. Further, the Encapsulation provides additional benefits including bypassing water solubility limitations of LJC and modulating the release of this molecule. The different properties of PA–LJC nanostructures results in different killing profiles, and reduced cytotoxicity and hemolytic activity. Meanwhile, details in membrane alterations caused by each strategy were revealed by various microscopy and fluorescent techniques. Last, in vivo studies in larvae treated by the Encapsulation strategy showed better antimicrobial efficacy than polymyxin B. Collectively, this study established a multifunctional platform using a versatile PA to act as an antibiotic, membrane-penetrating assistant, and slow-release delivery vehicle.Keywords
Funding Information
- US-Egypt Joint Board on Scientific and Technological Cooperation (72026321CA00001)
- National Science Foundation (DMR-1941731)
- Consejo Nacional de Investigaciones Científicas y Técnicas (ANPCyT PICT 1520-2019)
This publication has 49 references indexed in Scilit:
- Conformal Electrodeposition of Antimicrobial Hydrogels Formed by Self‐Assembled Peptide AmphiphilesAdvanced Materials Interfaces, 2023
- Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutionsJournal of Biosciences, 2021
- Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant eraActa Pharmaceutica Sinica B, 2021
- A Chemical Disruptor of the ClpX Chaperone Complex Attenuates the Virulence of Multidrug‐Resistant Staphylococcus aureusAngewandte Chemie International Edition, 2017
- Biophysics in cancer: The relevance of drug-membrane interaction studiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2016
- The ClpXP Protease Unfolds Substrates Using a Constant Rate of Pulling but Different GearsCell, 2013
- Influence of Nanostructure Morphology on Host Capacity and Kinetics of Guest ReleaseSmall, 2011
- Self‐assembly of peptide amphiphiles: From molecules to nanostructures to biomaterialsPeptide Science, 2010
- Development of bioactive peptide amphiphiles for therapeutic cell deliveryActa Biomaterialia, 2010
- In vitro hemolysis: Guidance for the pharmaceutical scientistJournal of Pharmaceutical Sciences, 2006